Biosimilars Check Up: Physician Survey Results

By AmerisourceBergen

Learn Physicians’ Perspectives on Biosimilars 

To uncover the biggest hurdles facing biosimilars today, AmerisourceBergen surveyed 100 physicians for their insights on issues like barriers to adoption and cost. The results reveal a market that, though not yet mature, has great potential to deliver on the promise of cost savings.

As stakeholders across healthcare seek to understand how biosimilars can be utilized, it is critical to understand how physicians view these products. 

Enter Your Information to Access the Whitepaper